Clinical outcomes following hospital-wide implementation of prolonged-infusion cefepime and ceftazidime

International Journal of Antimicrobial Agents

Volumn 46, Issue 1, 2015, Pages 129-130

  Turner, R Brigg ^a   Slain, Douglas ^b   Petros, Karen ^b   Keller, Lisa A ^b   Sarwari, Arif R ^c  

^a PACIFIC UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTAZIDIME; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

BACTERIUM CULTURE; BACTERIUM ISOLATION; DRUG EFFICACY; DRUG INFUSION; GRAM NEGATIVE INFECTION; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LENGTH OF STAY; LETTER; MEDICAL RECORD; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; TREATMENT DURATION; ADULT; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PROCEDURES; SURVIVAL; TIME; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; CEPHALOSPORINS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INFUSIONS, INTRAVENOUS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84935019468     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.03.007     Document Type: Letter

References (4)

1. Lodise TP, Lomaestro BM, Drusano GL. Society of Infectious Diseases Pharmacists Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on β-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 2006;26:1320-32.
2. Georges B, Conil JM, Cougot P, Decun JF, Archambaud M, Sequin T, et al. Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen. Int J Clin Pharmacol Ther 2005;43:360-9.
3. Bauer K, West JE, O'Brien JM, Goff DA. Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections. Antimicrob Agents Chemother 2013;57:2907-12.
4. Keel RA, Kuti JL, Sahm DF, Nicolau DP. Pharmacodynamic evaluation of i.v. antimicrobials against Pseudomonas aeruginosa samples collected from U.S. hospitals. Am J Health Syst Pharm 2011;68:1619-25.